Drawing for NUFORCE

USPTO serial 76356733

NUFORCE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
GILBERT, REBECCA L
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NUFORCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cory M. Amron

CORY M AMRON VORYS, SATER, SEYMOUR AND PEASE LLP1828 L ST 11TH FLWASHINGTON, DC 20036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009FLEXIBLE MAGNETIC MATERIAL OF VARIOUS SHAPES AND SIZES, NAMELY, SHEETING AND EXTRUSIONS FOR USE IN CONNECTION WITH DISPLAYS AND SIGNSACTIVE
010FLEXIBLE MAGNETS OF VARIOUS SHAPES AND SIZES FOR BIOMAGNETIC MEDICAL PURPOSES SUCH AS SHOE INSERTS AND BACK SUPPORT INSERTSACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 21, 2005MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 21, 2005ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 7, 2005EX4GSOU EXTENSION 4 GRANTED
Apr 7, 2005EXT4SOU EXTENSION 4 FILED
Apr 7, 2005MAILPAPER RECEIVED
Oct 28, 2004EX3GSOU EXTENSION 3 GRANTED
Sep 24, 2004EXT3SOU EXTENSION 3 FILED
Sep 24, 2004MAILPAPER RECEIVED
Apr 19, 2004EX2GSOU EXTENSION 2 GRANTED
Apr 9, 2004CFITCASE FILE IN TICRS
Mar 30, 2004EXT2SOU EXTENSION 2 FILED
Mar 30, 2004MAILPAPER RECEIVED
Nov 5, 2003EX1GSOU EXTENSION 1 GRANTED
Oct 10, 2003EXT1SOU EXTENSION 1 FILED
Oct 10, 2003MAILPAPER RECEIVED
Apr 15, 2003NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 21, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 1, 2003NPUBNOTICE OF PUBLICATION
Nov 26, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 25, 2002CNEAEXAMINERS AMENDMENT MAILED
Nov 18, 2002DOCKASSIGNED TO EXAMINER
Nov 18, 2002ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN
Oct 1, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 24, 2002CNEAEXAMINERS AMENDMENT MAILED
May 1, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 22, 2002DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance